HENDERSON, Nev. (AP) _ Spectrum Pharmaceuticals Inc. (SPPI) on Tuesday reported a loss of $28.6 million in its fourth quarter.
The Henderson, Nevada-based company said it had a loss of 29 cents per share.
The biotechnology company posted revenue of $28.6 million in the period.
For the year, the company reported that its loss widened to $91.2 million, or $1.07 per share. Revenue was reported as $128.4 million.
Spectrum Pharma expects full-year revenue in the range of $90 million to $110 million.
Spectrum Pharma shares have risen 11 percent since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $21.09, more than tripling in the last 12 months.